Top

Strahlentherapie und Onkologie

Published in:

01-01-2014 | Literatur kommentiert

Die Chemotherapiesequenz vor oder nach Strahlentherapie hat keinen Einfluss auf das Überleben der Kinder mit Hochrisiko-Medulloblastomen

Ergebnisse der multizentrischen und randomisierten Studie der Pediatric Oncology Group (POG 9031)

Author: R.-D. Kortmann

Published in: Strahlentherapie und Onkologie | Issue 1/2014

Auszug

Tarbell NJ, Friedman H, Polkinghorn WR et al. (2013) High-risk medulloblastoma: a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031) J Clin Oncol 31:2936–41 …

Chi SN, Gardner SL, Levy AS et al (2004) Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. J Clin Oncol 22:4881–4887PubMedCrossRef

Evans AE, Jenkin RD, Sposto R et al (1990) The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 72:572–582PubMedCrossRef

Gandola L, Massimino M, Cefalo G et al (2009) Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma. J Clin Oncol 27:566–571PubMedCrossRef

Krischer JP, Ragab AH, Kun L et al (1991) Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group study. J Neurosurg 74:905–909PubMedCrossRef

Mosijczuk AD, Nigro MA, Thomas PR et al (1993) Preradiation chemotherapy in advanced medulloblastoma. A Pediatric Oncology Group pilot study. Cancer 72:2755–2762PubMedCrossRef

Packer RJ, Sutton LN, Elterman R et al (1994) Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 81:690–698PubMedCrossRef

Tait DM, Thornton-Jones H, Bloom HJ et al (1990) Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 26:464–469PubMed

Taylor RE, Bailey CC, Robinson KJ et al (2005) Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy. Eur J Cancer 41:727–734PubMedCrossRef

10.

Hoff K von, Hinkes B, Gerber NU et al (2009) Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT’91. Eur J Cancer 45:1209–1217CrossRef

11.

Zeltzer PM, Boyett JM, Finlay JL et al (1999) Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children’s Cancer Group 921 randomized phase III study. J Clin Oncol 17:832–845PubMed

Title: Die Chemotherapiesequenz vor oder nach Strahlentherapie hat keinen Einfluss auf das Überleben der Kinder mit Hochrisiko-Medulloblastomen
Ergebnisse der multizentrischen und randomisierten Studie der Pediatric Oncology Group (POG 9031)
Author: R.-D. Kortmann
Publication date: 01-01-2014
Publisher: Springer Berlin Heidelberg
Published in: Strahlentherapie und Onkologie / Issue 1/2014
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-013-0491-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Die Chemotherapiesequenz vor oder nach Strahlentherapie hat keinen Einfluss auf das Überleben der Kinder mit Hochrisiko-Medulloblastomen

Ergebnisse der multizentrischen und randomisierten Studie der Pediatric Oncology Group (POG 9031)

Auszug

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Auszug

Please log in to get access to this content

Other articles of this Issue 1/2014

Fibroblast growth factor 2 is of prognostic value for patients with locally advanced squamous cell carcinoma of the head and neck

From heart to heart for breast cancer patients—cardiovascular toxicities in breast cancer radiotherapy

Prostate positioning using cone-beam computer tomography based on manual soft-tissue registration

Volumetric evaluation of an alternative bladder point in brachytherapy for locally advanced cervical cancer

Patterns of care in patients with cervical cancer 2012

A survival score for patients with brain metastases from less radiosensitive tumors treated with whole-brain radiotherapy alone